https://orcid.org/0000-0002-1557-3413
Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Stephane Alexandre Regnier & Xin Ying Lee. (2023) Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention. Journal of Medical Economics 26:1, pages 1072-1080.
Read now
Read now
D. Willems, C. J. Sayed, H. H. Van der Zee, J. R. Ingram, E.-L. Hinzpeter, C. Beaudart, S. M. A. A. Evers & M. Hiligsmann. (2023) A discrete-choice experiment to elicit the treatment preferences of patients with hidradenitis suppurativa in the United States. Journal of Medical Economics 26:1, pages 503-508.
Read now
Read now
Monika Tomaszewska-Kiecana, Anna Dryja, Martin Ullmann, Corinne Petit-Frere, Andras Illes, Christos Dagres & Joëlle Monnet. (2023) Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults. Expert Review of Clinical Immunology 19:4, pages 447-455.
Read now
Read now
Alessandro Mannucci, Ferdinando D’Amico, Ahmad El Saadi, Laurent Peyrin-Biroulet & Silvio Danese. (2022) Filgotinib for moderately to severely active ulcerative colitis. Expert Review of Gastroenterology & Hepatology 16:10, pages 927-940.
Read now
Read now
Christopher J. Rini, Bruce C. Roberts, Aishwarya Vaidyanathan, Aojun Li, Rick Klug, Douglas B. Sherman & Ronald J. Pettis. (2022) Enabling faster subcutaneous delivery of larger volume, high viscosity fluids. Expert Opinion on Drug Delivery 19:9, pages 1165-1176.
Read now
Read now
Articles from other publishers (13)
Sophia A. Cordes, Alexandra R. Nesson, Joaquin Calderon, Dinan S. Abdelatif & Homa K. Ahmadzia. (2023) Acceptability of intramuscular injection of tranexamic acid in postpartum hemorrhage prevention. AJOG Global Reports 3:2, pages 100195.
Crossref
Crossref
Ole Haagen Nielsen, Theresa Louise Boye, John Gubatan, Deepavali Chakravarti, James B. Jaquith & Eric C. LaCasse. (2023) Selective JAK1 inhibitors for the treatment of inflammatory bowel disease. Pharmacology & Therapeutics 245, pages 108402.
Crossref
Crossref
Amir Erfani, Antonio E. Diaz & Patrick S. Doyle. (2023) Hydrogel-enabled, local administration and combinatorial delivery of immunotherapies for cancer treatment. Materials Today 65, pages 227-243.
Crossref
Crossref
James F HowardJrJr, Saskia Bresch, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D Weiss, Małgorzata Zajda, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W Duda, Romana Lowcock, Mark Vanderkelen, M Isabel Leite, Dylan Sembinelli, Jeanne Teitelbaum, Michael Nicolle, Emilien Bernard, Juliette Svahn, Marco Spinazzi, Tanya Stojkovic, Sophie Demeret, Nicolas Weiss, Loïc Le Guennec, Sihame Messai, Christine Tranchant, Aleksandra Nadaj-Pakleza, Jean-Baptiste Chanson, Muhtadi Suliman, Leila Zaidi, Celine Tard, Peggy Lecointe, Jana Zschüntzsch, Jens Schmidt, Stefanie Glaubitz, Rachel Zeng, Matthias Scholl, Markus Kowarik, Ulf Ziemann, Markus Krumbholz, Pascal Martin, Christoph Ruschil, Jutta Dünschede, Roswitha Kemmner, Natalie Rumpel, Benjamin Berger, Andreas Totzeck, Tim Hagenacker, Benjamin Stolte, Raffaele Iorio, Amelia Evoli, Silvia Falso, Carlo Antozzi, Rita Frangiamore, Fiammetta Vanoli, Elena Rinaldi, Kazushi Deguchi, Naoya Minami, Yuriko Nagane, Yasushi Suzuki, Sayaka Ishida, Shigeaki Suzuki, Jin Nakahara, Astushi Nagaoka, Shunsuke Yoshimura, Shingo Konno, Youko Tsuya, Akiyuki Uzawa, Tomoya Kubota, Masanori Takahashi, Tatsusada Okuno, Hiroyuki Murai, Nils Erik Gilhus, Marion Boldingh, Tone Hakvåg Rønning, Urszula Chyrchel-Paszkiewicz, Klaudiusz Kumor, Tomasz Zielinski, Krzysztof Banaszkiewicz, Michał Błaż, Agata Kłósek, Mariola Świderek-Matysiak, Andrzej Szczudlik, Aneta Paśko, Lech Szczechowski, Marta Banach, Jan Ilkowski, Solange Kapetanovic Garcia, Patricia Ortiz Bagan, Ana Belén Cánovas Segura, Joana Turon Sans, Nuria Vidal Fernandez, Elena Cortes Vicente, Patricia Rodrigo Armenteros, Mohammad Ashraghi, Ana Cavey, Liam Haslam, Anna Emery, Kore Liow, Sharon Yegiaian, Alexandru Barboi, Rosa Maria Vazquez, Joshua Lennon, Robert M Pascuzzi, Cynthia Bodkin, Sandra Guingrich, Adam Comer, Mark Bromberg, Teresa Janecki, Sami Saba, Marco Tellez, Bakri Elsheikh, Miriam Freimer, Sarah Heintzman, Raghav Govindarajan, Jeffrey Guptill, Janice M Massey, Vern Juel, Natalia Gonzalez, Ali A Habib, Tahseen Mozaffar, Manisha Korb, Namita Goyal, Hannah Machemehl, Georgios Manousakis, Jeffrey Allen, Emily Harper, Constantine Farmakidis, Lilli Saavedra, Mazen Dimachkie, Mamatha Pasnoor, Salma Akhter, Said Beydoun, Courtney McIlduff, Joan Nye, Bhaskar Roy, Bailey Munro Sheldon, Richard Nowak, Benjamin Barnes, Michael Rivner, Niraja Suresh, Jessica Shaw, Brittany Harvey, Lucy Lam, Nikki Thomas, Manisha Chopra, Rebecca E Traub, Sarah Jones, Mary Wagoner, Sejla Smajic, Radwa Aly, Jonathan Katz, Henry Chen, Robert G Miller, Liberty Jenkins, Shaida Khan, Bhupendra Khatri, Lisa Sershon, Pantelis Pavlakis, Shara Holzberg, Yuebing Li, Irys B Caristo, Robert Marquardt, Debbie Hastings, Jacob Rube, Robert P Lisak, Aparna Choudhury, Katherine Ruzhansky, Amit Sachdev, Susan Shin, Joan Bratton, Mary Fetter, Naya McKinnon, Jonathan McKinnon, Laura Sissons-Ross, Amos Sahu & B Jane Distad. (2023) Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. The Lancet Neurology 22:5, pages 395-406.
Crossref
Crossref
A. M. Alonso Torres, A. G. Arévalo Bernabé, N. Becerril Ríos, M. F. Hellín Gil, J. M. Martínez Sesmero, V. Meca Lallana, Ll. Ramió-Torrentà, A. Rodríguez-Antigüedad, L. Gómez Maldonado, I. Triana Junco, M. Gómez-Barrera, N. Espinoza Cámac & I. Oyagüez. (2023) Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain. PharmacoEconomics - Open 7:3, pages 431-441.
Crossref
Crossref
Zhenhua Xu, Jocelyn H. Leu, Yan Xu, Ivo Nnane, Sophia G. Liva, Shun Xin Wang‐Lin, Rachel Kudgus‐Lokken, An Vermeulen & Daniele Ouellet. (2023) Development of Therapeutic Proteins for a New Subcutaneous Route of Administration After the Establishment of Intravenous Dosages: A Systematic Review. Clinical Pharmacology & Therapeutics 113:5, pages 1011-1029.
Crossref
Crossref
Marquerita Algorri, Nina S. Cauchon, Twinkle Christian, Chelsea O'Connell & Pujita Vaidya. (2023) Patient-Centric Product Development: A Summary of Select Regulatory CMC and Device Considerations. Journal of Pharmaceutical Sciences 112:4, pages 922-936.
Crossref
Crossref
Damon Willems, Eva-Lotta Hinzpeter, Hessel H. Van der Zee, Christopher J. Sayed, John R. Ingram, Charlotte Beaudart, Silvia M. A. A. Evers & Mickael Hiligsmann. (2023) Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The Patient - Patient-Centered Outcomes Research 16:2, pages 153-164.
Crossref
Crossref
Alexander M. Curreri, Jayoung Kim, Michael Dunne, Pavimol Angsantikul, Morgan Goetz, Yongsheng Gao & Samir Mitragotri. (2023) Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics. Advanced Science 10:7, pages 2205389.
Crossref
Crossref
Ferdinando D’Amico, Fernando Magro, Laurent Peyrin-Biroulet & Silvio Danese. (2022) Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis. Journal of Crohn's and Colitis 16:5, pages 835-844.
Crossref
Crossref
Jan Marsal, Manuel Barreiro-de Acosta, Irina Blumenstein, Maria Cappello, Thomas Bazin & Shaji Sebastian. (2022) Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Frontiers in Medicine 9.
Crossref
Crossref
Corrado Pelaia, Alessandro Casarella, Gianmarco Marcianò, Lucia Muraca, Vincenzo Rania, Rita Citraro, Caterina Palleria, Roberta Roberti, Giulia Pelaia, Giovambattista De Sarro & Luca Gallelli. (2021) Asthma Control during COVID-19 Lockdown in Patients with Severe Asthma under Biological Drug Treatment. Applied Sciences 11:24, pages 12089.
Crossref
Crossref
Carlos Taxonera, María Pilar Martínez-Montiel, Manuel Barreiro-de-Acosta, Isabel Vera, Rufo Lorente, Pablo Vega, María Teresa Diz-Lois, Ana María Fuentes Coronel, José Lázaro Pérez Calle, Begoña Casis, Rocío Ferreiro-Iglesias, Marta Calvo, David Olivares & Cristina Alba. (2021) Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study. Therapeutic Advances in Gastroenterology 14, pages 175628482110561.
Crossref
Crossref